Cardiovascular Digital Solutions Market Size, Share & Trends Analysis Report By Service Type (Unobtrusive Testing, CVD Health Informatics), By Component, By Deployment, By End-use, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global cardiovascular digital solutions market size was exhibited at USD 102.9 billion in 2022 and is projected to hit around USD 166.02 billion by 2032, growing at a CAGR of 4.9% during the forecast period 2023 to 2032.

Cardiovascular Digital Solutions Market Size

Key Pointers:

  • The unobtrusive testing segment accounted for the largest revenue share of 39.9% in 2022.
  • The devices segment accounted for the largest revenue share of 74.14% in 2022 and is expected to continue its dominance with the fastest growth rate of 4.11% in the forecast period.
  • The cloud-based segment accounted for the largest revenue share of 67.19% in 2022 and is expected to continue its dominance with the fastest growth rate of 5.2% over the forecast period. 
  • The hospitals & clinics segment accounted for the largest revenue share of 50.26% in 2022 and is expected to continue its dominance with the fastest growth rate of over 5.1% from 2023-2030.
  • The ambulatory care centers are expected to witness a CAGR of 4.9% during the forecast period.
  • North America dominated the market and accounted for the largest revenue share of 40.3% in 2022. 
  • The Asia Pacific cardiovascular digital solutions market is anticipated to witness rapid growth in the forecast period with a CAGR of 5.4%.

 Cardiovascular Digital Solutions Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 107.94 Billion

Market Size by 2032

USD 166.02 Billion

Growth Rate from 2023 to 2032

CAGR of 4.9%

Base year

2022

Forecast period

2023 to 2032

Segments covered

Service type, Components, Deployment, End-use

Regional scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key companies profiled

iRythm Technologies, Inc.; Apple Inc.; GENERAL ELECTRIC COMPANY; Uber Diagnostics; AlivCor, Inc.; Verily Life Sciences LLC; HeartFlow; Inc.; Bardy Diagnostics, Inc.; Bio Telemetry; Inc.; Koninklijke Philips N.V.; eviCore healthcare

 

Cardiovascular diseases are the most common cause of mortality and morbidity and require a detailed multi-parameter evaluation beyond the ECG. Digital solutions are important for monitoring patients, early detection, and intervention of cardiac conditions to make cardiac care more tailored and efficient. The increase in the prevalence of cardiovascular diseases globally and the rapid advancement in healthcare technology worldwide are some of the major factors driving the growth of the cardiovascular digital solutions market.

The COVID-19 pandemic caused a mild decline in the cardiovascular digital solutions market. The COVID-19 pandemic brought a global crisis for the major world economies, specifically the healthcare industry. Key players in the market continued to alter their plans in response to the constantly shifting circumstances. However, different countries and key players in the market had undertaken critical healthcare modifications until the emergency takes a back seat.

North America dominated the market and accounted for the largest revenue share of 40.3% in 2022. This is owing to the rapid technological advancements in the medical sector and the highly developed health infrastructure of the region. In addition, the rise in the prevalence of cardiovascular conditions is further increasing the growth of the market. As per the article published by Future Science Group on “As per the article published by Future Science Group, an estimated 3.6 million heart failure hospitalizations and 7.6 million diagnosed prevalent chronic heart failure (CHF) cases were witnessed in North America in 2020.

The Asia Pacific cardiovascular digital solutions market is anticipated to witness rapid growth in the forecast period with a CAGR of 5.4%. The increase in the geriatric population and the development of cardiac health management technology in Asian countries are driving the growth of the regional market. As per the article published by JACC journals on "Epidemiological Features of Cardiovascular Disease in Asia" cardiovascular disease (CVD) continues to be the leading cause of death and premature death worldwide. Around 58% of the 18.6 million CVD fatalities that occurred globally in 2019 were in Asia. As the nation with the highest population density and the widest diversity of cultures, ethnicities, socioeconomic status, and health care systems, Asia Pacific faces numerous challenges in cardiovascular disease prevention and treatment.

Cardiovascular Digital Solutions Market Segmentation

By Service Type By Components By Deployment By End-use
  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs
  • Others
  • Devices
  • Software
  • Cloud-Based
  • On-premise
  • Hospitals & Clinics
  • Ambulatory care centers
  • Others

Frequently Asked Questions

The global cardiovascular digital solutions market size was exhibited at USD 102.9 billion in 2022 and is projected to hit around USD 166.02 billion by 2032

Some key players operating in the iRythm Technologies, Inc., Apple Inc., GENERAL ELECTRIC COMPANY, Uber Diagnostics, AlivCor, Inc., Verily Life Sciences LLC, HeartFlow, Inc., Bardy Diagnostics, Inc., Bio Telemetry, Inc., Koninklijke Philips N.V., eviCore healthcare.

North America dominated the cardiovascular digital solutions market with a share of around 40.3% in 2022 owing to the highly developed healthcare infrastructure and the rising prevalence of cardiovascular diseases.

Key factors driving the market growth include the increase in the geriatric population, increased technological advancements in cardiovascular disease management, and increased prevalence of cardiovascular conditions.

Chapter 1 Report Scope And Objectives
                   1.1 Market Segmentation & Scope
                   1.2 Regional Scope
                       1.2.1 Estimates And Forecast Timeline
                   1.3 Objectives
                       1.3.1 Objective - 1
                       1.3.2 Objective - 2
                       1.3.3 Objective - 3
Chapter 2 Methodology
                   2.1 Research Methodology
                   2.2 Information Procurement
                       2.2.1 Purchased Database
                       2.2.2 Nova one advisor’s Internal Database
                       2.2.3 Secondary Sources
                       2.2.4 Primary Research
                   2.3 Information Or Data Analysis
                       2.3.1 Data Analysis Models
                   2.4 Market Formulation & Validation
                   2.5 Model Details
                       2.5.1 Commodity Flow Analysis (Model 1)
                       2.5.2 Volume Price Analysis (Model 2)
                   2.6 List Of Secondary Sources
Chapter 3 Executive Summary
                   3.1 Market Outlook
                   3.2 Segment Outlook
                       3.2.1 Service Type
                       3.2.2 Components
                       3.2.3 Deployment
                       3.2.4 End-Use
                       3.2.5 Region
                   3.3 Competitive Insights
                   3.4 Cardiovascular Digital Solutions Market Outlook, 2023
Chapter 4 Market Variables, Trends & Scope
                   4.1 Market Lineage Outlook
                       4.1.1 Parent Market Outlook
                   4.2 Cardiovascular Digital Solutions Market Dynamics
                       4.2.1 Market Driver Analysis
                       4.2.2 Market Restraint Analysis
                   4.3 Cardiovascular Digital Solutions Market: Business Environment Analysis Tools
                       4.3.1 Porter’s Five Forces Analysis
                           4.3.1.1 Threat Of New Entrants
                           4.3.1.2 Bargaining Power Of Suppliers
                           4.3.1.3 Bargaining Power Of Buyers
                           4.3.1.4 Competitive Rivalry
                           4.3.1.5 Threat Of Substitutes
                       4.3.2 Pestel Analysis
                           4.3.2.1 Political & Legal
                           4.3.2.2 Economic & Social
                           4.3.2.3 Technological
                   4.4 Penetration & Growth Prospect Mapping
                   4.5 Technology Trend Analysis
                   4.6 Regulatory Framework
                   4.7 Impact Of Covid-19 On Cardiovascular Digital Solutions Market
Chapter 5 Cardiovascular Digital Solutions Market: Service Type Analysis
                   5.1 Cardiovascular Digital Solutions Service Type Market Share Analysis, 2023 & 2032
                   5.2 Cardiovascular Digital Solutions, Deployment, Market: Segment Dashboard
                   5.3 Market Size & Forecasts And Trend Analyses, 2020 To 2032 For Service Type Segment
                       5.3.1 Unobtrusive Testing
                           5.3.1.1 Unobtrusive Testing Market, 2020 - 2032
                       5.3.2 Cvd Health Informatics
                           5.3.2.1 Cvd Health Informatics Market, 2020 - 2032
                       5.3.3 Cardiac Rehab Programs
                           5.3.3.1 Cardiac Rehab Programs Market, 2020 - 2032
                       5.3.4 Others
                           5.3.4.1 Others Market, 2020 - 2032
Chapter 6 Cardiovascular Digital Solutions Market: Components Analysis
                   6.1 Cardiovascular Digital Solutions Components Market Share Analysis, 2023 & 2032
                   6.2 Cardiovascular Digital Solutions Components Market: Segment Dashboard
                   6.3 Market Size & Forecasts And Trend Analyses, 2020 To 2032 For Components Segment
                       6.3.1 Devices
                           6.3.1.1 Devices Market, 2020 - 2032
                       6.3.2 Software
                           6.3.2.1 Software Market, 2020 - 2032
Chapter 7 Cardiovascular Digital Solutions Market: Deployment Analysis
                   7.1 Cardiovascular Digital Solutions Deployment Market Share Analysis, 2023 & 2032
                   7.2 Cardiovascular Digital Solutions Deployment Market: Segment Dashboard
                   7.3 Market Size & Forecasts And Trend Analyses, 2020 To 2032 For Components Segment
                       7.3.1 Cloud-Based
                           7.3.1.1 Cloud-Based Market 2020 - 2032
                       7.3.2 On-Premise
                           7.3.2.1 On-Premise Market, 2020 - 2032
Chapter 8 Cardiovascular Digital Solutions Market: End-Use Analysis
                   8.1 Cardiovascular Digital Solutions End-Use Market Share Analysis, 2021 & 2032
                   8.2 Cardiovascular Digital Solutions End-Use Market: Segment Dashboard
                   8.3 Market Size & Forecasts And Trend Analyses, 2020 To 2032 For The End-Use Segment
                       8.3.1 Hospitals & Clinics
                           8.3.1.1 Hospitals & Clinics Market, 2020 - 2032
                       8.3.2 Ambulatory Care Centers
                           8.3.2.1 Ambulatory Care Centers Market, 2020 - 2032
                       8.3.3 Others
                           8.3.3.1 Others Market, 2020 - 2032
Chapter 9 Cardiovascular Digital Solutions Market: Regional Analysis
                   9.1 Cardiovascular Digital Solutions Regional Market Share Analysis, 2023 & 2032
                   9.2 Regional Market Snapshot
                   9.3 North America
                       9.3.1 North America Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.3.2 U.S.
                           9.3.2.1 U.S. Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.3.3 Canada
                           9.3.3.1 Canada Cardiovascular Digital Solutions Market, 2020 - 2032
                   9.4 Europe
                       9.4.1 Europe Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.4.2 U.K.
                           9.4.2.1 U.K. Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.4.3 Germany
                           9.4.3.1 Germany Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.4.4 France
                           9.4.4.1 France Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.4.5 Italy
                           9.4.5.1 Italy Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.4.6 Spain
                           9.4.6.1 Spain Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.4.7. Russia
                           9.4.7.1 Russia Cardiovascular Digital Solutions Market, 2020 - 2032
                   9.5 Asia Pacific
                       9.5.1 Asia Pacific Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.2 Japan
                           9.5.2.1 Japan Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.3 China
                           9.5.3.1 China Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.4 India
                           9.5.4.1 India Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.5 Australia
                           9.5.5.1 Australia Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.6 South Korea
                           9.5.6.1 South Korea Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.7 Singapore
                           9.5.7.1 Singapore Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.8 Thailand
                           9.5.8.1 Thailand Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.5.9 Malaysia
                           9.5.9.1 Malaysia Cardiovascular Digital Solutions Market, 2020 - 2032
                   9.6 Latin America
                       9.6.1 Latin America Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.6.2 Brazil
                           9.6.2.1 Brazil Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.6.3 Mexico
                           9.6.3.1 Mexico Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.6.4 Colombia
                           9.6.4.1 Colombia Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.6.5 Argentina
                           9.6.5.1 Argentina Cardiovascular Digital Solutions Market, 2020 - 2032
                   9.7 Middle East And Africa (Mea)
                       9.7.1 Mea Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.7.2 South Africa
                           9.7.2.1 South Africa Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.7.3 Saudi Arabia
                           9.7.3.1 Saudi Arabia Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.7.4 Uae
                           9.7.4.1 Uae Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.7.5 Kuwait
                           9.7.5.1 Kuwait Cardiovascular Digital Solutions Market, 2020 - 2032
                       9.7.6 Israel
                           9.7.6.1 Israel Cardiovascular Digital Solutions Market, 2020 - 2032
Chapter 10 Competitive Analysis
                   10.1 Recent Developments & Impact Analysis, By Key Market Participants
                   10.2 Company Profiles
                   10.3 Irythm Technologies, Inc.
                       10.3.1 Company Overview
                       10.3.2 Financial Performance
                       10.3.3 Product Benchmarking
                       10.3.4 Strategic Initiatives
                   10.4 Apple Inc.
                       10.4.1 Company Overview
                       10.4.2 Financial Performance
                       10.4.3 Product Benchmarking
                       10.4.4 Strategic Initiatives
                   10.5 General Electric Company
                       10.5.1 Company Overview
                       10.5.2 Financial Performance
                       10.5.3 Product Benchmarking
                       10.5.4 Strategic Initiatives
                   10.6 Uber Diagnostics
                       10.6.1 Company Overview
                       10.6.2 Financial Performance
                       10.6.3 Product Benchmarking
                       10.6.4 Strategic Initiatives
                   10.7 Alivcor, Inc.
                       10.7.1 Company Overview
                       10.7.2 Financial Performance
                       10.7.3 Product Benchmarking
                       10.7.4 Strategic Initiatives
                   10.8 Verily Life Sciences Llc,
                       10.8.1 Company Overview
                       10.8.2 Financial Performance
                       10.8.3 Product Benchmarking
                       10.8.4 Strategic Initiatives
                   10.9 Heartflow, Inc.
                       10.9.1 Company Overview
                       10.9.2 Financial Performance
                       10.9.3 Product Benchmarking
                       10.9.4 Strategic Initiatives
                   10.10 Bardy Diagnostics, Inc.
                       10.10.1 Company Overview
                       10.10.2 Financial Performance
                       10.10.3 Product Benchmarking
                       10.10.4 Strategic Initiatives
                   10.11 Bio Telemetry, Inc.
                       10.11.1 Company Overview
                       10.11.2 Financial Performance
                       10.11.3 Product Benchmarking
                       10.11.4 Strategic Initiatives
                   10.12 Koninkelijke Philips N.V.
                       10.12.1 Company Overview
                       10.12.2 Financial Performance
                       10.12.3 Product Benchmarking
                       10.12.4 Strategic Initiatives
                   10.13 Evicore Healthcare
                       10.13.1 Company Overview
                       10.13.2 Financial Performance
                       10.13.3 Product Benchmarking
                       10.13.4 Strategic Initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert